<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK62111" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK62111/" /><meta name="ncbi_pagename" content="Kabuki Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Kabuki Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Kabuki Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/10/21" /><meta name="citation_author" content="Margaret P Adam" /><meta name="citation_author" content="Louanne Hudgins" /><meta name="citation_author" content="Mark Hannibal" /><meta name="citation_pmid" content="21882399" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK62111/" /><meta name="citation_keywords" content="Kabuki Make-Up Syndrome" /><meta name="citation_keywords" content="Niikawa-Kuroki Syndrome" /><meta name="citation_keywords" content="Kabuki Make-Up Syndrome" /><meta name="citation_keywords" content="Niikawa-Kuroki Syndrome" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase 2D" /><meta name="citation_keywords" content="Lysine-specific demethylase 6A" /><meta name="citation_keywords" content="KDM6A" /><meta name="citation_keywords" content="KMT2D" /><meta name="citation_keywords" content="Kabuki Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Kabuki Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Margaret P Adam" /><meta name="DC.Contributor" content="Louanne Hudgins" /><meta name="DC.Contributor" content="Mark Hannibal" /><meta name="DC.Date" content="2019/10/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK62111/" /><meta name="description" content="Kabuki syndrome (KS) is characterized by typical facial features (long palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; large, prominent, or cupped ears), minor skeletal anomalies, persistence of fetal fingertip pads, mild-to-moderate intellectual disability, and postnatal growth deficiency. Other findings may include: congenital heart defects; genitourinary anomalies; cleft lip and/or palate; gastrointestinal anomalies including anal atresia, ptosis, and strabismus; and widely spaced teeth and hypodontia. Functional differences can include: increased susceptibility to infections and autoimmune disorders, seizures, endocrinologic abnormalities (including isolated premature thelarche in females), feeding problems, and hearing loss." /><meta name="og:title" content="Kabuki Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Kabuki syndrome (KS) is characterized by typical facial features (long palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; large, prominent, or cupped ears), minor skeletal anomalies, persistence of fetal fingertip pads, mild-to-moderate intellectual disability, and postnatal growth deficiency. Other findings may include: congenital heart defects; genitourinary anomalies; cleft lip and/or palate; gastrointestinal anomalies including anal atresia, ptosis, and strabismus; and widely spaced teeth and hypodontia. Functional differences can include: increased susceptibility to infections and autoimmune disorders, seizures, endocrinologic abnormalities (including isolated premature thelarche in females), feeding problems, and hearing loss." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK62111/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kabuki/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK62111/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B3A68E041FDC10000000004CA01E7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK62111_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK62111_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kmt2b-dystonia/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kos/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK62111_"><span class="title" itemprop="name">Kabuki Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Kabuki Make-Up Syndrome, Niikawa-Kuroki Syndrome</div><p class="contrib-group"><span itemprop="author">Margaret P Adam</span>, MD, MS, FAAP, FACMG, <span itemprop="author">Louanne Hudgins</span>, MD, and <span itemprop="author">Mark Hannibal</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK62111_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK62111_ai__"><div class="contrib half_rhythm"><span itemprop="author">Margaret P Adam</span>, MD, MS, FAAP, FACMG<div class="affiliation small">Department of Pediatrics<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcelttaes@mada.teragram" class="oemail">gro.snerdlihcelttaes@mada.teragram</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Louanne Hudgins</span>, MD<div class="affiliation small">Division of Medical Genetics<br />Stanford University<br />Palo Alto, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.drofnats@snigduhl" class="oemail">ude.drofnats@snigduhl</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Mark Hannibal</span>, MD, PhD<div class="affiliation small">Division of Genetics<br />Department of Pediatrics and Communicable Diseases<br />University of Michigan Medical School<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu@labinnah" class="oemail">ude.hcimu@labinnah</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 1, 2011</span>; Last Revision: <span itemprop="dateModified">October 21, 2019</span>.</p><p><em>Estimated reading time: 30 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kabuki.Summary" itemprop="description"><h2 id="_kabuki_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Kabuki syndrome (KS) is characterized by typical facial features (long palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; large, prominent, or cupped ears), minor skeletal anomalies, persistence of fetal fingertip pads, mild-to-moderate intellectual disability, and postnatal growth deficiency. Other findings may include: <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects; genitourinary anomalies; cleft lip and/or palate; gastrointestinal anomalies including anal atresia, ptosis, and strabismus; and widely spaced teeth and hypodontia. Functional differences can include: increased susceptibility to infections and autoimmune disorders, seizures, endocrinologic abnormalities (including <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> premature thelarche in females), feeding problems, and hearing loss.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of KS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> of any age with a history of infantile hypotonia, developmental delay, and/or intellectual disability AND one or both of the following:</p><ul><li class="half_rhythm"><div>Typical <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features (long palpebral fissures with eversion of the lateral third of the lower eyelid, and &#x02265;2 of the following: arched and broad eyebrows with the lateral third displaying notching or sparseness; short columella with depressed nasal tip; large, prominent, or cupped ears; persistent fingertip pads)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KMT2D</i> or a heterozygous or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variant in <i>KDM6A</i></div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Thickened feedings and positioning after meals to treat gastroesophageal reflux; gastrostomy tube placement if feeding difficulties are severe. If cognitive difficulties are evident, psychoeducational testing and special education services to address the individual child's needs. Evaluation by a developmental pediatrician or psychiatrist if behavior suggests autism spectrum disorders. Standard antiepileptic treatment for seizures.</p><p><i>Prevention of secondary complications:</i> Prophylactic antibiotic treatment prior to and during any procedure (e.g., dental work) may be indicated for those with specific heart defects.</p><p><i>Surveillance:</i> Monitor height, weight, and head circumference at each well-child visit and, at a minimum, yearly. Developmental milestones should be followed with each well-child visit. Monitor vision and hearing on a yearly basis.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>KMT2D</i>-related KS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; <i>KDM6A</i>-related KS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><ul><li class="half_rhythm"><div><i>Autosomal dominant inheritance</i>. The proportion of KS caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KMT2D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown but is likely high based on clinical experience. In the rare case that a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div><i><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</i>. If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and may have features of KS.</div></li></ul><p>Once the causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for KS are possible.</p></div></div><div id="kabuki.Diagnosis"><h2 id="_kabuki_Diagnosis_">Diagnosis</h2><p>Consensus clinical diagnostic criteria for Kabuki syndrome (KS) have been published [<a class="bk_pop" href="#kabuki.REF.adam.2019.89">Adam et al 2019</a>].</p><div id="kabuki.Suggestive_Findings"><h3>Suggestive Findings</h3><p>KS <b>should be suspected</b> in individuals with any combination of the <b>five cardinal manifestations</b> as defined by <a class="bk_pop" href="#kabuki.REF.niikawa.1988.565">Niikawa et al [1988]</a>, specific <b>structural anomalies</b>, and/or <b>functional differences</b>.</p><p><b>Cardinal manifestations</b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Typical facial features:</p><ul><li class="half_rhythm"><div>Long palpebral fissures with eversion of the lateral third of the lower eyelid</div></li><li class="half_rhythm"><div>Highly arched and broad eyebrows with the lateral third displaying sparseness or notching</div></li><li class="half_rhythm"><div>Short columella with depressed nasal tip</div></li><li class="half_rhythm"><div>Large, prominent, and/or cupped ears</div></li></ul></dd><dt>2.</dt><dd><p class="no_top_margin">Skeletal anomalies:</p><ul><li class="half_rhythm"><div>Spine abnormalities including sagittal clefts, hemivertebrae, butterfly vertebrae, narrow intervertebral disc space, and/or scoliosis</div></li><li class="half_rhythm"><div>Brachydactyly V</div></li><li class="half_rhythm"><div>Brachymesophalangy</div></li><li class="half_rhythm"><div>Clinodactyly of fifth digits</div></li></ul></dd><dt>3.</dt><dd><p class="no_top_margin">Dermatoglyphic abnormalities: persistence of fetal fingertip pads</p><p>Note: While absence of digital triradius c and/or d and increased digital loop and hypothenar loop patterns can be observed, this type of analysis is not routinely done in clinical practice in most centers.</p></dd><dt>4.</dt><dd><p class="no_top_margin">Mild-to-moderate intellectual disability</p></dd><dt>5.</dt><dd><p class="no_top_margin">Postnatal growth deficiency</p></dd></dl><p><b>Structural anomalies</b> in KS can include the following:</p><ul><li class="half_rhythm"><div>Ophthalmologic anomalies including ptosis and strabismus</div></li><li class="half_rhythm"><div>Ear pits (a potentially helpful diagnostic clue when seen with other typical findings)</div></li><li class="half_rhythm"><div>Cleft lip and/or palate</div></li><li class="half_rhythm"><div>Dental anomalies including widely spaced teeth and hypodontia</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Gastrointestinal anomalies including anal atresia</div></li><li class="half_rhythm"><div>Genitourinary anomalies including cryptorchidism in males</div></li></ul><p><b>Functional differences</b> can include the following:</p><ul><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Feeding problems</div></li><li class="half_rhythm"><div>Endocrinologic abnormalities including <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> premature thelarche in females</div></li><li class="half_rhythm"><div>Increased susceptibility to infections and autoimmune disorders</div></li><li class="half_rhythm"><div>Seizures</div></li></ul></div><div id="kabuki.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of KS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> of any age with a history of infantile hypotonia, developmental delay, and/or intellectual disability AND one or both of the following [<a class="bk_pop" href="#kabuki.REF.adam.2019.89">Adam et al 2019</a>]:</p><ul><li class="half_rhythm"><div>Typical <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features (see *) at some point of life</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KMT2D</i> or a heterozygous or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variant in <i>KDM6A</i> (<a class="figpopup" href="/books/NBK62111/table/kabuki.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figkabukiTmoleculargenetictestingused" rid-ob="figobkabukiTmoleculargenetictestingused">Table 1</a>)</div></li></ul><p>*&#x000a0;Typical <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features include long palpebral fissures (a palpebral fissure measurement &#x02265;2 SD above the mean for age) with eversion of the lateral third of the lower eyelid AND two or more of the following:</p><ul><li class="half_rhythm"><div>Arched and broad eyebrows with the lateral third displaying notching or sparseness</div></li><li class="half_rhythm"><div>Short columella with depressed nasal tip</div></li><li class="half_rhythm"><div>Large, prominent, or cupped ears</div></li><li class="half_rhythm"><div>Persistent fingertip pads</div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Kabuki syndrome is broad, individuals with the distinctive findings described in <a href="#kabuki.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#kabuki.Option_1">Option 1</a>), whereas those in whom the diagnosis of Kabuki syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#kabuki.Option_2">Option 2</a>).</p><div id="kabuki.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Kabuki syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>KMT2D</i> and <i>KDM6A</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</p><ul><li class="half_rhythm"><div>Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KMT2D</i> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div>Sequence analysis and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>KDM6A</i> can be considered next if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li></ul><p>Note: Affected individuals with classic features who have a mosaic <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KMT2D</i> have been reported; therefore, <a class="bk_pop" href="#kabuki.REF.lepri.2017.e82">Lepri et al [2017]</a> suggested that targeted <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> may be a more appropriate method of mutation detection compared to traditional <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a>.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KMT2D</i>, <i>KDM6A</i>, and other genes of interest (see <a href="#kabuki.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK62111/table/kabuki.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figkabukiTmoleculargenetictestingused" rid-ob="figobkabukiTmoleculargenetictestingused">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="kabuki.Option_2"><h4>Option 2</h4><p>When the diagnosis of Kabuki syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic &#x02013; and particularly when evidence supports <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="kabuki.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Kabuki Syndrome (KS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of KS Attributed to Pathogenic Variants in Gene</th><th id="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KDM6A</i></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%-5%&#x000a0;<sup>6</sup></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~80%&#x000a0;<sup>6</sup></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~20%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2D</i></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~75%&#x000a0;<sup>6</sup></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%&#x000a0;<sup>8</sup></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5 reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>10,&#x000a0;11</sup></td><td headers="hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_2 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_1_3 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_1 hd_h_kabuki.T.molecular_genetic_testing_used_1_1_2_2" colspan="3" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kabuki.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="kabuki.TF.1.2"><p class="no_margin">See <a href="/books/NBK62111/#kabuki.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="kabuki.TF.1.3"><p class="no_margin">See <a href="#kabuki.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="kabuki.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="kabuki.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="kabuki.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al [2016]</a>, <a class="bk_pop" href="#kabuki.REF.cocciadiferro.2018.3651">Cocciadiferro et al [2018]</a>, <a class="bk_pop" href="#kabuki.REF.yap.2019.262">Yap et al [2019]</a></p></div></dd><dt>7. </dt><dd><div id="kabuki.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#kabuki.REF.van_laarhoven.2015.4443">Van Laarhoven et al [2015]</a>, <a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al [2016]</a>, <a class="bk_pop" href="#kabuki.REF.cocciadiferro.2018.3651">Cocciadiferro et al [2018]</a>, <a class="bk_pop" href="#kabuki.REF.yap.2019.262">Yap et al [2019]</a></p></div></dd><dt>8. </dt><dd><div id="kabuki.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#kabuki.REF.hannibal.2011.1511">Hannibal et al [2011]</a>, <a class="bk_pop" href="#kabuki.REF.li.2011.715">Li et al [2011]</a>, <a class="bk_pop" href="#kabuki.REF.micale.2011.38">Micale et al [2011]</a>, <a class="bk_pop" href="#kabuki.REF.paulussen.2011.e2018">Paulussen et al [2011]</a>, <a class="bk_pop" href="#kabuki.REF.banka.2012.381">Banka et al [2012]</a>, <a class="bk_pop" href="#kabuki.REF.makrythanasis.2013.539">Makrythanasis et al [2013]</a>, <a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al [2016]</a></p></div></dd><dt>9. </dt><dd><div id="kabuki.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#kabuki.REF.banka.2012.381">Banka et al [2012]</a>, <a class="bk_pop" href="#kabuki.REF.riess.2012.94">Riess et al [2012]</a>, <a class="bk_pop" href="#kabuki.REF.cocciadiferro.2018.3651">Cocciadiferro et al [2018]</a></p></div></dd><dt>10. </dt><dd><div id="kabuki.TF.1.10"><p class="no_margin">For approximately 30% of individuals with a clinical diagnosis of Kabuki syndrome, the genetic cause remains unknown. Therefore, <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity for one or more as-yet-unidentified genes remains a possibility [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2013.201">B&#x000f6;gershausen &#x00026; Wollnik 2013</a>].</p></div></dd><dt>11. </dt><dd><div id="kabuki.TF.1.11"><p class="no_margin">Further candidate genes for KS or conditions with features that overlap with KS include <i>RAP1A</i>, <i>RAP1B</i>, and <i>KDM6C</i> [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al 2016</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="kabuki.Clinical_Characteristics"><h2 id="_kabuki_Clinical_Characteristics_">Clinical Characteristics</h2><div id="kabuki.Clinical_Description"><h3>Clinical Description</h3><p>This section summarizes findings in more than 400 individuals with a molecularly confirmed diagnosis of Kabuki syndrome (KS).</p><div id="kabuki.Growth"><h4>Growth</h4><p>Individuals with KS typically exhibit normal growth parameters at birth.</p><ul><li class="half_rhythm"><div>Infants with KS frequently exhibit failure to thrive for a variety of reasons (see <a href="#kabuki.Gastrointestinal">Gastrointestinal</a>).</div></li><li class="half_rhythm"><div>In adolescence and adulthood, more than half of individuals with KS develop obesity [<a class="bk_pop" href="#kabuki.REF.cheon.2015.317">Cheon &#x00026; Ko 2015</a>], which can exacerbate other health problems, such as recurrent patellar dislocation (see <a href="#kabuki.Musculoskeletal">Musculoskeletal</a>).</div></li><li class="half_rhythm"><div>Without treatment (see <a href="#kabuki.Endocrine">Endocrine</a>, <b>Short stature</b>), postnatal growth deficiency is evident by age 12 months. Lack of a typical growth spurt during puberty exacerbates short stature [<a class="bk_pop" href="#kabuki.REF.schott.2016a.3172">Schott et al 2016a</a>]. Microcephaly may or may not accompany short stature.</div></li></ul></div><div id="kabuki.Ophthalmologic"><h4>Ophthalmologic</h4><p>Ocular findings occur in more than one third of individuals with Kabuki syndrome and include blue sclerae, strabismus, ptosis, coloboma, Marcus Gunn phenomenon (also referred to as jaw winking), and corneal abnormalities such as Peters anomaly.</p><ul><li class="half_rhythm"><div>Rarely, more severe eye anomalies may occur, such as optic nerve hypoplasia, colobomatous microphthalmia, and anophthalmia [<a class="bk_pop" href="#kabuki.REF.chen.2014.143">Chen et al 2014</a>, <a class="bk_pop" href="#kabuki.REF.mcveigh.2015.135">McVeigh et al 2015</a>].</div></li><li class="half_rhythm"><div>Functional visual problems may include difficulties with motor coordination, visuoperception, and visuomotor integration [<a class="bk_pop" href="#kabuki.REF.caciolo.2018.322">Caciolo et al 2018</a>]. Failure to detect and treat these issues can exacerbate learning problems [<a class="bk_pop" href="#kabuki.REF.lehman.2017.298">Lehman et al 2017</a>].</div></li><li class="half_rhythm"><div>As a result of the everted lower eyelid, children with KS can demonstrate excessive tearing, which is not usually a significant problem. However, nocturnal lagophthalmos, which occurs in many children with KS, can predispose to corneal abrasion and scarring.</div></li></ul></div><div id="kabuki.Ears_and_Hearing"><h4>Ears and Hearing</h4><p>Most individuals with KS have prominent and cup-shaped ears. Ear pits are also relatively common.</p><p>From a medical standpoint, chronic otitis media is a major cause of morbidity, including conductive hearing loss. It is not clear, however, whether this finding is related to an underlying susceptibility to infection or to the craniofacial abnormalities, such as palatal insufficiency.</p><p>Up to 50% of individuals with KS have hearing loss. Although chronic otitis media is the most common cause, sensorineural hearing loss can rarely occur and some individuals have progressive hearing loss. Inner-ear malformations including Mondini dysplasia, vestibular enlargement, aplastic cochlea and semicircular canals, and aqueductal enlargement have been reported. At least one individual with a clinical diagnosis of Kabuki syndrome who had profound progressive sensorineural hearing loss received a cochlear implant with a reported improvement in quality of life [<a class="bk_pop" href="#kabuki.REF.vesseur.2016.129">Vesseur et al 2016</a>].</p></div><div id="kabuki.Craniofacial"><h4>Craniofacial</h4><p>Cleft lip and/or palate affects approximately one third of individuals with KS. Submucous cleft palate may be underascertained [<a class="bk_pop" href="#kabuki.REF.paik.2016.474">Paik &#x00026; Lim 2016</a>]. Almost three quarters of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a high-arched palate. As with all children with palatal abnormalities, feeding difficulties, frequent otitis media, and speech difficulties are more common in this subset of affected individuals. A number of individuals have lower lip pits [<a class="bk_pop" href="#kabuki.REF.porntaveetus.2018.381">Porntaveetus et al 2018</a>].</p><p>The typical facial features (elongated palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; and large, prominent, or cupped ears) are considered part of the diagnostic criteria of KS and are therefore present in almost all individuals who have a clinical diagnosis of KS. A majority of individuals with a molecularly confirmed diagnosis of KS are also found to have these characteristic facial features [<a class="bk_pop" href="#kabuki.REF.adam.2019.89">Adam et al 2019</a>].</p></div><div id="kabuki.Dental"><h4>Dental</h4><p>A number of different dental anomalies in individuals with KS have been noted [<a class="bk_pop" href="#kabuki.REF.porntaveetus.2018.381">Porntaveetus et al 2018</a>]. Hypodontia is most common, with absent lateral upper incisors, absent lower incisors, ectopic upper six-year molars, and missing second premolars also being described. Abnormally shaped teeth (e.g., flathead-screwdriver-shaped appearance of the upper incisors), small teeth, widely spaced teeth, and malocclusion may also be seen.</p></div><div id="kabuki.Cardiovascular"><h4>Cardiovascular</h4><p>Approximately 70% of individuals with KS have a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect [<a class="bk_pop" href="#kabuki.REF.digilio.2017.2912">Digilio et al 2017</a>]. Many heart defects have been described in association with KS, but left-sided obstructive lesions, especially coarctation of the aorta, are the most common. Other defects may include (alone or in combination): septal defects, bicuspid aortic valve, mitral valve anomalies, conotruncal heart defects, and hypoplastic left heart syndrome. Hypertrophic cardiomyopathy and aortic root dilation have been occasionally reported.</p></div><div id="kabuki.Respiratory"><h4>Respiratory</h4><p>Eventration of the diaphragm has been rarely reported [<a class="bk_pop" href="#kabuki.REF.zarate.2012.180">Zarate et al 2012</a>].</p><p>Laryngeal abnormalities may pose problems with anesthesia (see Management, <a href="#kabuki.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p></div><div id="kabuki.Gastrointestinal"><h4>Gastrointestinal</h4><p>Feeding difficulties are quite common (~70%) and may be related to hypotonia, poor oromotor coordination, and swallowing difficulties [<a class="bk_pop" href="#kabuki.REF.cheon.2015.317">Cheon &#x00026; Ko 2015</a>] that may require nasogastric or gastrostomy tube placement. Many individuals with KS have gastroesophageal reflux.</p><p>Abnormalities involving the gastrointestinal system are not common in KS; however, the following may be seen rarely:</p><ul><li class="half_rhythm"><div>Anorectal anomalies including imperforate anus, anovestibular fistula, and anteriorly placed anus [<a class="bk_pop" href="#kabuki.REF.siminas.2015.54">Siminas et al 2015</a>]</div></li><li class="half_rhythm"><div>Congenital diaphragmatic hernia and eventration of the diaphragm</div></li><li class="half_rhythm"><div>Cholestasis from a variety of causes</div></li><li class="half_rhythm"><div>Chronic diarrhea from malabsorption and/or celiac disease</div></li></ul></div><div id="kabuki.Genitourinary"><h4>Genitourinary</h4><p>Renal and urinary tract anomalies are seen in more than 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#kabuki.REF.courcet.2013.742">Courcet et al 2013</a>]. Common renal findings include anomalies of kidney position and ascent (single fused kidneys, crossed fused renal ectopia) and renal dysplasia; hydronephrosis is the most common urinary tract finding. Other anomalies may include ureteropelvic junction obstruction and duplication of the collecting system. Hypospadias and cryptorchidism can occur in males [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2013.201">B&#x000f6;gershausen &#x00026; Wollnik 2013</a>].</p></div><div id="kabuki.Musculoskeletal"><h4>Musculoskeletal</h4><p>Joint hypermobility is seen in 50%-75% of individuals with KS. Joint dislocations, especially involving the hips, patellae, and shoulders, are not uncommon. As in most conditions with joint laxity, this finding improves with age.</p><ul><li class="half_rhythm"><div>Variable degrees of scoliosis and kyphosis are seen and may be associated with vertebral anomalies (hemivertebrae, butterfly vertebrae, sagittal clefts).</div></li><li class="half_rhythm"><div>Persistent fetal fingertip pads are considered one of the five cardinal manifestations of KS and are therefore found in a large proportion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#kabuki.REF.adam.2019.89">Adam et al 2019</a>].</div></li><li class="half_rhythm"><div>Absence of digital triradius c and/or d and increased digital loop and hypothenar loop patterns can also be observed, although analysis for these features is not frequently done in current clinical practice.</div></li><li class="half_rhythm"><div>Other hand findings (brachydactyly V, brachymesophalangy, and clinodactyly of the 5th digits) can also be seen, but these features rarely lead to clinical issues and are used more as a clue to the diagnosis (see <a href="#kabuki.Suggestive_Findings">Suggestive Findings</a>).</div></li></ul></div><div id="kabuki.Endocrine"><h4>Endocrine</h4><p><b>Premature thelarche</b> in girls is the most common endocrine abnormality described (16%-41%) [<a class="bk_pop" href="#kabuki.REF.banka.2012.381">Banka et al 2012</a>]. This finding does not represent premature puberty and is likely to resolve with time.</p><p><b>Short stature,</b> even absent growth hormone deficiency, has responded to growth hormone therapy without exacerbating disproportion:</p><ul><li class="half_rhythm"><div>In a study by <a class="bk_pop" href="#kabuki.REF.schott.2016a.3172">Schott et al [2016a]</a>, average adult height without growth hormone therapy was between -2.99 SD (standard deviations) and -1.08 SD in males and between -5.57 and -1.47 SD in females.</div></li><li class="half_rhythm"><div>After one year of growth hormone treatment, the average height standard deviation score improved from -2.40 to -1.69 [<a class="bk_pop" href="#kabuki.REF.schott.2016b.319">Schott et al 2016b</a>].</div></li><li class="half_rhythm"><div>Those who initiated growth hormone therapy at an earlier age received the most benefit in terms of catch-up growth.</div></li><li class="half_rhythm"><div>After one year of growth hormone therapy, body proportions were not significantly affected.</div></li></ul><p><b>Hyperinsulinism</b> is likely underascertained in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and may be a presenting sign in neonates.</p><ul><li class="half_rhythm"><div>Failure to recognize and treat hyperinsulinism in a timely fashion can lead to irreversible neurologic damage and exacerbate developmental issues.</div></li><li class="half_rhythm"><div>It is estimated that about 1% of neonates with hyperinsulinism have a diagnosis of Kabuki syndrome [<a class="bk_pop" href="#kabuki.REF.yap.2019.262">Yap et al 2019</a>].</div></li></ul><p><b>Other.</b> The following findings have been described in a small subset of individuals with KS in the literature:</p><ul><li class="half_rhythm"><div>Adrenal insufficiency</div></li><li class="half_rhythm"><div>Combined pituitary hormone deficiency</div></li><li class="half_rhythm"><div>Diabetes insipidus</div></li><li class="half_rhythm"><div>Frank growth hormone deficiency</div></li><li class="half_rhythm"><div>Hypothyroidism</div></li><li class="half_rhythm"><div>Primary ovarian dysfunction</div></li><li class="half_rhythm"><div>True precocious puberty</div></li></ul></div><div id="kabuki.Immunologic"><h4>Immunologic</h4><p>Immune dysfunction including both humoral immune deficiency and autoimmune disease has been described [<a class="bk_pop" href="#kabuki.REF.lindsley.2016.179">Lindsley et al 2016</a>]. Clinical findings in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may mimic those seen in individuals with common variable immune deficiency.</p><ul><li class="half_rhythm"><div>Frequent and recurrent infections, such as frequent sinopulmonary infections and recurrent otitis media, are found in a majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#kabuki.REF.lin.2015.255">Lin et al 2015</a>].</div></li><li class="half_rhythm"><div>Hypogammaglobulinemia and IgA deficiency are common.</div></li><li class="half_rhythm"><div>Diminished B-cell populations have also been reported [<a class="bk_pop" href="#kabuki.REF.lindsley.2016.179">Lindsley et al 2016</a>].</div></li><li class="half_rhythm"><div>Autoimmune conditions such as vitiligo, immune thrombocytopenia (ITP), hemolytic anemia, and even diabetes mellitus have also been described in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, most commonly in childhood or adolescence [<a class="bk_pop" href="#kabuki.REF.brackmann.2013.e314">Brackmann et al 2013</a>, <a class="bk_pop" href="#kabuki.REF.giordano.2014.10">Giordano et al 2014</a>, <a class="bk_pop" href="#kabuki.REF.lindsley.2016.179">Lindsley et al 2016</a>].</div></li></ul></div><div id="kabuki.Neurologic"><h4>Neurologic</h4><p>Most children with KS are hypotonic and joint laxity may be a contributing factor.</p><ul><li class="half_rhythm"><div>Hypotonia may contribute to significant feeding problems in infancy (see <a href="#kabuki.Growth">Growth</a>). As with other conditions in which hypotonia is a feature, this finding tends to improve with age.</div></li><li class="half_rhythm"><div>Seizures are seen more frequently in KS (10%-39%) than in the general population and represent a spectrum of findings including infantile spasms [<a class="bk_pop" href="#kabuki.REF.liu.2015.26">Liu et al 2015</a>]. Good seizure control is generally achieved with standard anti-seizure medications.</div></li></ul></div><div id="kabuki.Neuroimaging"><h4>Neuroimaging</h4><p>Although most people with Kabuki syndrome undergo brain imaging at some point for indications such as seizures and/or developmental delay, major structural brain anomalies are rare. Reported findings have included the following [<a class="bk_pop" href="#kabuki.REF.banka.2015.252">Banka et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.liu.2015.26">Liu et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.teranishi.2018.391">Teranishi et al 2018</a>]:</p><ul><li class="half_rhythm"><div>Cerebellar and brain stem atrophy</div></li><li class="half_rhythm"><div>Dandy-walker malformation</div></li><li class="half_rhythm"><div>Delayed myelination</div></li><li class="half_rhythm"><div>Mild ventriculomegaly</div></li></ul><p>Note: Prior to the identification of the genetic causes of KS, symptomatic Chiari I malformation was reported in multiple <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#kabuki.REF.ciprero.2005.273">Ciprero et al 2005</a>]. This specific finding has not been highlighted in recent publications on individuals with a confirmed molecular diagnosis. However, this does not preclude symptomatic Chiari I malformation as a clinical feature in individuals with molecularly confirmed KS.</p></div><div id="kabuki.Development"><h4>Development</h4><p>Intellectual disability, usually in the mild to moderate range, has been reported in a majority of individuals; however, reports of rare individuals with pathogenic variants in either <i>KMT2D</i> or <i>KDM6A</i> who have IQ levels above 70 have been published [<a class="bk_pop" href="#kabuki.REF.lederer.2012.119">Lederer et al 2012</a>, <a class="bk_pop" href="#kabuki.REF.cheon.2014.321">Cheon et al 2014</a>, <a class="bk_pop" href="#kabuki.REF.lederer.2014.1289">Lederer et al 2014</a>, <a class="bk_pop" href="#kabuki.REF.morgan.2015.1483">Morgan et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.butcher.2017.773">Butcher et al 2017</a>, <a class="bk_pop" href="#kabuki.REF.lehman.2017.298">Lehman et al 2017</a>, <a class="bk_pop" href="#kabuki.REF.sakata.2017.210">Sakata et al 2017</a>, <a class="bk_pop" href="#kabuki.REF.caciolo.2018.322">Caciolo et al 2018</a>]. Most individuals with KS are able to speak and to ambulate.</p><ul><li class="half_rhythm"><div>Average IQ scores in individuals with <i>KMT2D</i> pathogenic variants range from the high 50s to high 60s [<a class="bk_pop" href="#kabuki.REF.lehman.2017.298">Lehman et al 2017</a>, <a class="bk_pop" href="#kabuki.REF.caciolo.2018.322">Caciolo et al 2018</a>]. Rare case reports of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who are basically nonverbal have been published [<a class="bk_pop" href="#kabuki.REF.lindgren.2013.537">Lindgren et al 2013</a>, <a class="bk_pop" href="#kabuki.REF.miyake.2013.108">Miyake et al 2013</a>].</div></li><li class="half_rhythm"><div>Neuropsychiatric testing has identified deficits in both comprehension and production of verbal language, but this may be related, in part, to hearing, neurologic, orofacial, and cognitive deficits [<a class="bk_pop" href="#kabuki.REF.morgan.2015.1483">Morgan et al 2015</a>].</div><ul><li class="half_rhythm"><div>No specific language profile has been identified. However, all language subdomains including syntax, morphology, pragmatics, and semantics may be affected.</div></li><li class="half_rhythm"><div>Dysarthria (reduced rate and stress, distorted pitch, harsh vocal quality, hypernasality, and imprecise consonants) has also been described.</div></li><li class="half_rhythm"><div>On formal neuropsychiatric testing, individuals with KS tend to score better in the areas of vocabulary comprehension and working memory and score lower in the areas of nonverbal reasoning and processing speed [<a class="bk_pop" href="#kabuki.REF.lehman.2017.298">Lehman et al 2017</a>].</div></li></ul></li><li class="half_rhythm"><div>In terms of adaptive skills, individuals with KS have more difficulties with daily living than with communication.</div></li><li class="half_rhythm"><div>An educational environment that stresses audio-verbal learning over visual learning may beneficial (see <a href="#kabuki.Ophthalmologic">Ophthalmologic</a>).</div></li></ul></div><div id="kabuki.Behavior"><h4>Behavior</h4><p>Individuals with KS tend to be described as pleasant and outgoing.</p><ul><li class="half_rhythm"><div>Attention-deficit disorder and/or hyperactivity are present in a subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Other behavioral problems including anxiety disorder, self-harm, and sleep disturbance have been rarely reported [<a class="bk_pop" href="#kabuki.REF.banka.2015.252">Banka et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.caciolo.2018.322">Caciolo et al 2018</a>].</div></li><li class="half_rhythm"><div>Autism continues to be a rare but described finding in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#kabuki.REF.pad_rov_.2016.230">Pad&#x0011b;rov&#x000e1; et al 2016</a>, <a class="bk_pop" href="#kabuki.REF.sert_elik.2016.280">Sert&#x000e7;elik et al 2016</a>]. Whether this is truly part of the spectrum of KS or is a coincidental secondary diagnosis due to the frequency of autism spectrum disorders in the general population remains to be seen.</div></li></ul></div><div id="kabuki.Benign_Tumors"><h4>Benign Tumors</h4><p>Pilomatricomas, benign tumors of the hair shaft that commonly occur on the head and neck, have been described rarely in those with Kabuki syndrome [<a class="bk_pop" href="#kabuki.REF.bernier.2017.e26">Bernier et al 2017</a>]. In most cases, removal by a dermatologist is sufficient.</p></div><div id="kabuki.Malignancies"><h4>Malignancies</h4><p>Although pathogenic somatic variants in <i>KMT2D</i> and <i>KDM6A</i> have been seen in a variety of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> tumors [<a class="bk_pop" href="#kabuki.REF.huether.2014.3630">Huether et al 2014</a>], malignancies (primarily as case reports) have only been described in a few individuals with KS. There is no clear evidence of a significant predisposition to the development of cancer in individuals with KS [<a class="bk_pop" href="#kabuki.REF.roma.2015.80">Roma et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.karagianni.2016.1333">Karagianni et al 2016</a>]. Therefore, no tumor screening protocol for individuals with KS has been developed.</p></div></div><div id="kabuki.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b><i>KMT2D</i></b></p><ul><li class="half_rhythm"><div>Those with a <i>KMT2D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are more likely to have the distinctive Kabuki facial <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, which may reflect the fact that a portion of those without a <i>KMT2D</i> pathogenic variant may indeed have been misdiagnosed.</div></li><li class="half_rhythm"><div>In general, those with a <i>KMT2D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are also more likely to have renal anomalies, feeding problems, premature thelarche in females, joint dislocations, and palatal anomalies than are those without a <i>KMT2D</i> pathogenic variant [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2013.201">B&#x000f6;gershausen &#x00026; Wollnik 2013</a>, <a class="bk_pop" href="#kabuki.REF.courcet.2013.742">Courcet et al 2013</a>].</div></li></ul><p><b><i>KDM6A</i>.</b> The following are more common in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KDM6A</i> [<a class="bk_pop" href="#kabuki.REF.banka.2015.252">Banka et al 2015</a>, <a class="bk_pop" href="#kabuki.REF.yap.2019.262">Yap et al 2019</a>]:</p><ul><li class="half_rhythm"><div>Hypoglycemia due to hyperinsulinism</div></li><li class="half_rhythm"><div>Hypertrichosis</div></li><li class="half_rhythm"><div>Long halluces</div></li><li class="half_rhythm"><div>Large central incisors</div></li></ul><p>Affected males are more likely to have moderate-to-severe developmental delay / cognitive impairment than are females, who may have mild-to-moderate intellectual disability. In general, females with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KDM6A</i> tend to have milder features than <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, despite the fact that <i>KDM6A</i> escapes <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> [<a class="bk_pop" href="#kabuki.REF.banka.2015.252">Banka et al 2015</a>].</p></div><div id="kabuki.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>KMT2D</i></b></p><ul><li class="half_rhythm"><div>Heterozygous pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the terminal regions of <i>KMT2D</i> may increase the risk for autoimmune disease [<a class="bk_pop" href="#kabuki.REF.lindsley.2016.179">Lindsley et al 2016</a>].</div></li><li class="half_rhythm"><div>Those with whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>KMT2D</i> or pathogenic truncating variants that occur in the first half of the gene may have more severe intellectual disability [<a class="bk_pop" href="#kabuki.REF.lehman.2017.298">Lehman et al 2017</a>].</div></li></ul><p><b><i>KDM6A</i></b></p><ul><li class="half_rhythm"><div>Based on small numbers, pathogenic variants at the 3' end of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are more common than those at the 5' end [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al 2016</a>].</div></li><li class="half_rhythm"><div>Splice site variants, as compared to <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and small in/dels, are the most common type of singe-nucleotide variant [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al 2016</a>].</div></li></ul></div><div id="kabuki.Penetrance"><h3>Penetrance</h3><p>Penetrance for pathogenic variants in <i>KMT2D</i> appears to be complete; not enough information is available to make any conclusions regarding <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for those with pathogenic variants in <i>KDM6A</i>. Variable expressivity may lead to underascertainment of mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kabuki.Prevalence"><h3>Prevalence</h3><p>KS has been reported in almost all ethnic groups. The prevalence in Japan is estimated at 1:32,000 [<a class="bk_pop" href="#kabuki.REF.niikawa.1988.565">Niikawa et al 1988</a>]. The prevalence outside Japan presumably approximates that seen in the Japanese population.</p><p><a class="bk_pop" href="#kabuki.REF.white.2004.118">White et al [2004]</a> calculated a minimum birth incidence of 1:86,000 in Australia and New Zealand.</p></div></div><div id="kabuki.Genetically_Related_Allelic_Disor"><h2 id="_kabuki_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>KMT2D</i> or <i>KDM6A.</i></p></div><div id="kabuki.Differential_Diagnosis"><h2 id="_kabuki_Differential_Diagnosis_">Differential Diagnosis</h2><div id="kabuki.T.disorders_to_consider_in_the_di" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Kabuki Syndrome (KS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.T.disorders_to_consider_in_the_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.T.disorders_to_consider_in_the_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4" id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/KS</th><th headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4" id="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from KS</th></tr></thead><tbody><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/charge/">CHARGE syndrome</a></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Ocular coloboma</div></li><li class="half_rhythm"><div>Growth restriction</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In CHARGE syndrome:
<ul><li class="half_rhythm"><div>Square face</div></li><li class="half_rhythm"><div>Short, wide ear w/little or no earlobe</div></li><li class="half_rhythm"><div>Prominent columella</div></li><li class="half_rhythm"><div>Broad nasal root</div></li></ul>
In KS: fingertip pads</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gr_22q11deletion/">22q11.2 deletion syndrome</a></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Urinary tract anomalies</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In 22q11 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>:
<ul><li class="half_rhythm"><div>Short &#x00026; narrow palpebral fissures w/hooded eyelids</div></li><li class="half_rhythm"><div>Bulbous nasal tip</div></li><li class="half_rhythm"><div>Small, C-shaped ears w/overfolded superior &#x00026;/or lateral helices</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/vws/"><i>IRF6</i>-related disorders</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IRF6</i></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cleft lip &#x00026; palate</div></li><li class="half_rhythm"><div>Lip pits</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>IRF6</i>-related disorders are not assoc w/atypical growth &#x00026; development, cardiac malformations, or typical Kabuki syndrome facies.</div></li><li class="half_rhythm"><div>Pterygia is not expected in KS.</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bor/">Branchiootorenal (BOR) syndrome</a></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EYA1</i><br /><i>SIX5</i><br /><i>SIX1</i></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ear pits</div></li><li class="half_rhythm"><div>Cupped ears</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Renal anomalies</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In BOR syndrome:
<ul><li class="half_rhythm"><div>Otherwise normal craniofacies, growth, &#x00026; development</div></li><li class="half_rhythm"><div>Common renal anomalies incl renal hypoplasia &#x00026;/or agenesis; (vs in KS: common renal anomalies incl hydronephrosis &#x00026; malposition).</div></li><li class="half_rhythm"><div>Branchial cleft cysts may be present (not reported in KS).</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds3/">Hypermobile Ehlers-Danlos syndrome (EDS)</a></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Significant joint hypermobility (incl <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hip dislocation &#x00026; patellar dislocations)</div></li><li class="half_rhythm"><div>Blue sclerae</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Hypermobile EDS &#x00026; Larsen syndrome are not assoc w/major malformations involving other organ systems or the typical minor anomalies seen in KS.</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Larsen syndrome (see <a href="/books/n/gene/flnb-dis/"><i>FLNB</i>-Related Disorders</a>)</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNB</i></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> anomalies / variety of other <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> anomalies</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Similar facial features</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Growth retardation</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chromosome anomalies can easily be distinguished from KS by <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> analysis or CMA.</td></tr><tr><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hardikar syndrome<br />(OMIM <a href="http://www.omim.org/entry/612726" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612726</a>)</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Prolonged hyperbilirubinemia</div></li><li class="half_rhythm"><div>Cleft lip &#x00026; palate</div></li></ul>
</td><td headers="hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_1_4 hd_h_kabuki.T.disorders_to_consider_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individuals w/KS do not typically develop pigmentary retinopathy or sclerosing cholangitis, as seen in Hardikar syndrome.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; CHARGE = <i>c</i>oloboma, <i>h</i>eart defects, choanal <i>a</i>tresia, <i>r</i>etarded growth and development, <i>g</i>enital abnormalities, and <i>e</i>ar anomalies; CMA = <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="kabuki.TF.2.1"><p class="no_margin">Deletion of genes within the DiGeorge <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region is the only genetic abnormality known to be associated with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>.</p></div></dd><dt>2. </dt><dd><div id="kabuki.TF.2.2"><p class="no_margin"><i>IRF6</i>-related disorders span a spectrum from <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cleft lip and palate and Van der Woude syndrome at the mild end to popliteal pterygium syndrome at the more severe end.</p></div></dd><dt>3. </dt><dd><div id="kabuki.TF.2.3"><p class="no_margin">Dependent on anomaly</p></div></dd></dl></div></div></div></div><div id="kabuki.Management"><h2 id="_kabuki_Management_">Management</h2><p>Comprehensive management guidelines for Kabuki syndrome (KS) were developed in 2010 but have not been updated; these guidelines are available <a href="https://kr.ihc.com/ext/Dcmnt?ncid=521096055&#x00026;tfrm=default" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a> (pdf).</p><div id="kabuki.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and the needs of an individual diagnosed with KS, the following evaluations are recommended if they have not already been completed:</p><div id="kabuki.T.recommended_evaluations_followi" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Kabuki Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.T.recommended_evaluations_followi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.T.recommended_evaluations_followi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of height, weight, &#x00026; head circumference</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FTT is a common sequela of feeding difficulties.</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology evaluation</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For assessment of strabismus, refractive error, ptosis, &#x00026; corneal abnormalities</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline audiology evaluation</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for conductive &#x00026;/or sensorineural hearing loss</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mouth</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Directed evaluation of the palate for palatal anomalies</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a craniofacial specialist if palatal anomalies are suspected.</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consider dental evaluation for those age &#x0003e;3 yrs.</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram w/visualization of the aortic arch</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects incl coarctation of the aorta</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consider EKG.</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If arrhythmia is suspected</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider chest radiographs to assess for diaphragmatic eventuation.</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/respiratory issues, chronic cough, or recurrent pneumonia</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess nutritional status, feeding, GERD.</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Consider assessment by feeding team &#x00026;/or VFSS for those w/suspected dysphagia.</div></li><li class="half_rhythm"><div>Infants may have FTT; adolescents &#x00026; adults may have obesity.</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline renal ultrasound</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for renal anomalies &#x00026; hydronephrosis</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Physical examination for hypospadias &#x00026;/or cryptorchidism in males</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider radiographs of the spine in those w/scoliosis.</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for vertebral anomalies</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinologic</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for hyperinsulinism.&#x000a0;<sup>1</sup></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In neonates &#x00026; infants w/persistent hypoglycemia</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assess for hypothyroidism &#x00026; growth hormone deficiency.&#x000a0;<sup>2</sup></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/abnormal growth velocity</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immunologic</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T cell count, T cell subsets, &#x00026; serum immunoglobulin levels at time of diagnosis or at age 1 yr (whichever is later)</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to immunologist if:
<ul><li class="half_rhythm"><div>Levels are abnormal; or</div></li><li class="half_rhythm"><div>Patient has history of recurrent infections.</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EEG</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/suspected seizures</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Head MRI</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for:
<ul><li class="half_rhythm"><div>Structural brain malformation in those w/seizures</div></li><li class="half_rhythm"><div>Chiari I malformation in those w/suggestive symptoms&#x000a0;<sup>3</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Screen individuals age &#x0003e;12 mos for behavior concerns incl sleep disturbances, ADHD, anxiety, &#x00026;/or traits suggestive of ASD.</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate motor, speech/language, general cognitive, &#x00026; vocational skills.</td></tr><tr><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_kabuki.T.recommended_evaluations_followi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; FTT = failure to thrive; GERD = gastroesophageal reflux disease; VFSS = videofluoroscopic swallowing study</p></div></dd><dt>1. </dt><dd><div id="kabuki.TF.3.1"><p class="no_margin">This may include collection of a "critical sample," such as obtaining plasma levels of insulin, free fatty acids, beta-hydroxybutyrate, and glycemic response to glucagon during a period of low plasma glucose [<a class="bk_pop" href="#kabuki.REF.yap.2019.262">Yap et al 2019</a>].</p></div></dd><dt>2. </dt><dd><div id="kabuki.TF.3.2"><p class="no_margin">Thyroid function tests may include free T4 and TSH levels. Assessment for growth hormone deficiency can be challenging and is best directed by an endocrinologist. Tests may include measurement of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3, in addition to consideration of a growth hormone stimulation test using either arginine or clonidine [<a class="bk_pop" href="#kabuki.REF.schott.2016b.319">Schott et al 2016b</a>].</p></div></dd><dt>3. </dt><dd><div id="kabuki.TF.3.3"><p class="no_margin">Symptoms may include headaches, ocular disturbances, otoneurologic disturbances, lower cranial nerve signs, cerebellar ataxia, spasticity, or seizures.</p></div></dd></dl></div></div></div></div><div id="kabuki.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="kabuki.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Kabuki Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.T.treatment_of_manifestations_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Strabismus, refractive</b><br /><b>error, ptosis,</b><br /><b>lagophthalmos</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per ophthalmologist</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider:
<ul><li class="half_rhythm"><div>Pressure equalizing tubes for those w/conductive hearing loss;</div></li><li class="half_rhythm"><div>Hearing aids for those w/sensorineural hearing loss.&#x000a0;<sup>1</sup></div></li></ul>
</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to an ENT specialist &#x00026; audiologist; see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft lip &#x00026;/or palate</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Management through a specialized craniofacial clinic is ideal.</div></li><li class="half_rhythm"><div>The palate may be shorter, which can lead to velopharyngeal insufficiency after typical cleft repair.</div></li></ul>
</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental anomalies</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthodontic referral if hypodontia or significant malocclusion is noted</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defects &#x00026;/or arrhythmia</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per cardiologist</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">It is unclear whether risk for aortic aneurysm is &#x02191;; however, if catheterization or angioplasty is being considered, a potential &#x02191; risk of aortic aneurysm should be communicated to treating team.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding difficulties/GERD</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, which may incl thickening feeds &#x00026; appropriate positioning after meals in infants &#x00026; toddlers</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pharmacologic treatment for GERD may be considered.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consider gastrostomy tube.</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/severe feeding difficulties &#x00026;/or poorly coordinated suck &#x00026; swallow</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Chronic diarrhea</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to gastroenterologist.</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider evaluation for malabsorption &#x00026;/or celiac disease.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypospadias/</b><br /><b>Cryptorchidism</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per urologist</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hyperinsulinism &#x00026;</b><br /><b>hypothyroidism</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per endocrinologist</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Short stature</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider growth hormone therapy.</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to endocrinologist.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Recurrent infections</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intravenous immunoglobulin therapy may be considered in those w/documented immunoglobulin deficiency.</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to immunologist.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizure disorder</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard antiepileptic treatment per neurologist</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Short stature</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth hormone treatment may be considered.&#x000a0;<sup>2</sup></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to endocrinologist.</td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Premature thelarche</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No treatment is warranted if there are no other signs of premature puberty.</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Need for anesthesia</b></td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Care in positioning during intubation due to joint laxity, which can affect the cervical spine</td><td headers="hd_h_kabuki.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Educate regarding potential structural airway anomalies that could make intubation difficult.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kabuki.TF.4.1"><p class="no_margin">Cochlear implants can also be considered, as per ENT and audiologist recommendations.</p></div></dd><dt>2. </dt><dd><div id="kabuki.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#kabuki.REF.schott.2016a.3172">Schott et al [2016a]</a></p></div></dd></dl></div></div></div><p>See <a href="#kabuki.Therapies_Under_Investigation">Therapies Under Investigation</a> for discussion of histone deacetylase inhibitors and ketogenic diet as hypothesized treatments for individuals with KS. Currently neither of these therapies is recommended as a primary treatment for individuals with KS, outside of a clinical trial.</p><div id="kabuki.Developmental_Delay__Intellectual"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p>Neurodevelopmental therapies should target language and motor abilities to improve daily living skills and behaviors [<a class="bk_pop" href="#kabuki.REF.caciolo.2018.322">Caciolo et al 2018</a>].</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="kabuki.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p></div><div id="kabuki.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications, such as medication used to treat ADHD, when necessary.</p></div></div><div id="kabuki.Surveillance"><h3>Surveillance</h3><div id="kabuki.T.recommended_surveillance_for_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Kabuki Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.T.recommended_surveillance_for_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.T.recommended_surveillance_for_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of at least height &#x00026; weight&#x000a0;<sup>1</sup></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each appointment</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology or optometry to assess vision</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing assessment</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for scoliosis</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each appointment until skeletal maturity</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinologic</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thyroid function tests</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-3 yrs</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immunologic</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of complete blood count</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 2-3 yrs</td></tr><tr><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental progress &#x00026; educational needs.</td><td headers="hd_h_kabuki.T.recommended_surveillance_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit during childhood &#x00026; adolescence</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kabuki.TF.5.1"><p class="no_margin">Adolescents and adults may develop obesity.</p></div></dd></dl></div></div></div></div><div id="kabuki.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In those with joint laxity, activities that increase the risk of joint damage (e.g., bouncing on a trampoline) should be avoided.</p></div><div id="kabuki.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#kabuki.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kabuki.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Based on the function of <i>KMT2D</i> and <i>KDM6A</i> as regulators of chromatin expression (see <a href="#kabuki.Molecular_Genetics">Molecular Genetics</a>), it has been hypothesized that histone deacetylase inhibitors (HDACi) could have a beneficial effect on individuals with Kabuki syndrome. <a class="bk_pop" href="#kabuki.REF.bjornsson.2014.256ra135">Bjornsson et al [2014]</a> created a mouse model of KS and found that treatment with HDACi normalized the structural and functional differences seen in certain brain areas in these <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mice, leading to improved neurogenesis and memory. This has yet to be tested in humans with KS, but clinical trials based on these mouse studies are in the planning phase.</p><p>Since ketosis acts as an endogenous HDACi, others have hypothesized that placing individuals with KS on a ketogenic diet could improve their cognitive issues [<a class="bk_pop" href="#kabuki.REF.benjamin.2017.125">Benjamin et al 2017</a>]. This is NOT currently a recommended treatment for KS, although some families and physicians have trialed this diet independently. Since the ketogenic diet as a treatment for KS has not been studied as part of a clinical trial, no results of these types of experimental treatments are available in the peer-reviewed literature.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="kabuki.Genetic_Counseling"><h2 id="_kabuki_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kabuki.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>KMT2D</i>-related Kabuki syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><i>KDM6A</i>-related Kabuki syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="kabuki.Autosomal_Dominant_Inheritance__R"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>A minority of individuals diagnosed with <i>KMT2D</i>-related KS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>KMT2D</i>-related KS may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant was <i>de novo</i>, the proportion of <i>KMT2D</i>-related KS caused by a <i>de novo</i> pathogenic variant is unknown. However, based on clinical experience, the proportion of <i>KMT2D</i>-related KS caused by a <i>de novo</i> variant is likely high.</div></li><li class="half_rhythm"><div>Recommended evaluations for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include:</div><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has been identified. If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not known, clinical evaluation of the proband's parents, including a thorough physical examination by a clinical geneticist, is indicated to evaluate for any phenotypic features consistent with KS.</div></li></ul></li><li class="half_rhythm"><div>Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#kabuki.REF.banka.2013.467">Banka et al 2013</a>, <a class="bk_pop" href="#kabuki.REF.lepri.2017.e82">Lepri et al 2017</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>KMT2D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul></li><li class="half_rhythm"><div>If both parents are clinically unaffected but have not been tested for the <i>KMT2D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is not appropriate because a pathogenic variant has not been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>), the risk to the sibs of a proband appears to be low.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>KMT2D</i>-related Kabuki syndrome has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="kabuki.XLinked_Inheritance"><h3>X-Linked Inheritance</h3><div id="kabuki.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a heterozygote. About 80% of affected males represent simplex cases [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen et al 2016</a>].</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes and may have features of KS, although features in females tend to be milder than those in males (see <a href="#kabuki.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>KDM6A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Due to the small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and the relatively recent identification of <i>KDM6A</i> as a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> implicated in KS, no reports in the literature have described an affected male who has reproduced.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of being heterozygotes (carriers) for the pathogenic variant and/or being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="kabuki.Heterozygote_Carrier_Detection"><h4>Heterozygote (Carrier) Detection</h4><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. Note: Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder can have a range of clinical manifestations (see <a href="#kabuki.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</p></div></div><div id="kabuki.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or are carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kabuki.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Kabuki syndrome are possible.</p></div></div><div id="kabuki.Resources"><h2 id="_kabuki_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>All Things Kabuki</b></div><div><a href="https://www.allthingskabuki.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.allthingskabuki.org</a></div></li><li class="half_rhythm"><div><b>Kabuki Syndrome Network</b></div><div>8060 Struthers Crescent</div><div>Regina Saskatchewan S4Y 1J3</div><div>Canada</div><div><b>Phone:</b> 306-543-8715</div><div><b>Email:</b> margot@kabukisyndrome.com</div><div><a href="http://www.kabukisyndrome.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kabukisyndrome.com</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Kabuki%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Kabuki syndrome</a></div></li><li class="half_rhythm"><div><b>SAKKS: Supporting Aussie Kids with Kabuki Syndrome</b></div><div><b>Email:</b> petal@sakks.org</div><div><a href="http://www.sakks.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sakks.org</a></div></li></ul></div><div id="kabuki.Molecular_Genetics"><h2 id="_kabuki_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kabuki.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Kabuki Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kabuki.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kabuki.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kabuki.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kabuki.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_kabuki.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kabuki.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kabuki.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7403" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KDM6A</i></a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7403" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15550" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lysine-specific demethylase 6A</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/UTX" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UTX @ LOVD</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KDM6A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KDM6A</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KDM6A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KDM6A</a></td></tr><tr><td headers="hd_b_kabuki.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8085" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KMT2D</i></a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8085" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14686" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Histone-lysine N-methyltransferase 2D</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KMT2D" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KMT2D database</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KMT2D" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KMT2D</a></td><td headers="hd_b_kabuki.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KMT2D[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KMT2D</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kabuki.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kabuki.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Kabuki Syndrome (<a href="/omim/147920,300128,300867,602113" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK62111/table/kabuki.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kabuki.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147920" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147920</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KABUKI SYNDROME 1; KABUK1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300128" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300128</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LYSINE-SPECIFIC DEMETHYLASE 6A; KDM6A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300867" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300867</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KABUKI SYNDROME 2; KABUK2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602113" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602113</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LYSINE-SPECIFIC METHYLTRANSFERASE 2D; KMT2D</td></tr></tbody></table></div></div><div id="kabuki.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Both KDM6A and KMT2D work as part of a complex of proteins termed the ASCOM complex. The function of this complex is to remove repressive epigenetic marks and deposit activating <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> marks on chromatin. This then recruits RNA polymerase II complex, resulting in an activated chromatin state [<a class="bk_pop" href="#kabuki.REF.b_gershausen.2013.201">B&#x000f6;gershausen &#x00026; Wollnik 2013</a>]. KDM6A is an H3K27 demethylase that removes repressive polycomb-derived methylation marks [<a class="bk_pop" href="#kabuki.REF.agger.2007.731">Agger et al 2007</a>, <a class="bk_pop" href="#kabuki.REF.hong.2007.18439">Hong et al 2007</a>]. KMT2D is a histone 3 lysine 4 (H3K4) N-methyltransferase that specifically modifies the lysine residue at the fourth amino acid position of the histone H3 protein, catalyzing the conversion from nonmethylated to mono-, di-, and trimethylated H3K4. The SET <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of KMT2D is responsible for the methyltransferase activity [<a class="bk_pop" href="#kabuki.REF.kouzarides.2007.693">Kouzarides 2007</a>]. However, most target genes (and their respective functions) of the regulatory pathways in which KMT2D and KDM6A play a role are not yet known.</p><p><b>Mechanism of disease causation.</b> Loss of function of KDM6A or KMT2D causes Kabuki syndrome.</p><p><b><i>KDM6A-</i> or <i>KMT2D</i>-specific laboratory considerations.</b> Of note, <i>KDM6A</i> escapes <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</p></div><div id="kabuki.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p><b><i>KDM6A</i>.</b> Somatic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> have been described most commonly in urothelial carcinoma, T-cell acute lymphoblastic leukemia, and breast cancer, although a variety of cancers may harbor somatic variants in this gene [<a class="bk_pop" href="#kabuki.REF.schulz.2019.614">Schulz et al 2019</a>].</p><p><b><i>KMT2D.</i></b> Deleterious somatic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> have been described in a variety of different cancers including central nervous system, gastrointestinal, and hematopoietic malignancies [<a class="bk_pop" href="#kabuki.REF.ford.2015.178">Ford &#x00026; Dingwall 2015</a>, <a class="bk_pop" href="#kabuki.REF.rao.2015.334">Rao &#x00026; Dou 2015</a>].</p></div></div><div id="kabuki.References"><h2 id="_kabuki_References_">References</h2><div id="kabuki.Published_Guidelines__Consensus_S"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF1">Kabuki Syndrome Guideline Development Group. Management of Kabuki Syndrome &#x02013; A Clinical Guideline (pdf). Available <a href="https://kr.ihc.com/ext/Dcmnt?ncid=521096055&#x00026;tfrm=default" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2010. Accessed 10-8-19.</div></li></ul></div><div id="kabuki.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.adam.2019.89">Adam MP, Banka S, Bjornsson HT, Bodamer O, Chudley AE, Harris J, Kawame H, Lanpher BC, Lindsley AW, Merla G, Miyake N, Okamoto N, Stumpel CT, Niikawa N, et al.  Kabuki syndrome: international consensus diagnostic criteria. <span><span class="ref-journal">J Med Genet. </span>2019;<span class="ref-vol">56</span>:89–95.</span> [<a href="/pubmed/30514738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30514738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.agger.2007.731">Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, Salcini AE, Helin K. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">449</span>:731–4.</span> [<a href="/pubmed/17713478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17713478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.banka.2013.467">Banka S, Howard E, Bunstone S, Chandler KE, Kerr B, Lachlan K, McKee S, Mehta SG, Tavares AL, Tolmie J, Donnai D. MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:467–71.</span> [<a href="/pubmed/22901312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22901312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.banka.2015.252">Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S, Kerr B, McKee S, Lloyd IC, Shears D, Stewart H, White SM, Savarirayan R, Mancini GM, Beysen D, Cohn RD, Grisart B, Maystadt I, Donnai D. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">87</span>:252–8.</span> [<a href="/pubmed/24527667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24527667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.banka.2012.381">Banka S, Veeramachaneni R, Reardon W, Howard E, Bunstone S, Ragge N, Parker MJ, Crow YJ, Kerr B, Kingston H, Metcalfe K, Chandler K, Magee A, Stewart F, McConnell VP, Donnelly DE, Berland S, Houge G, Morton JE, Oley C, Revencu N, Park SM, Davies SJ, Fry AE, Lynch SA, Gill H, Schweiger S, Lam WW, Tolmie J, Mohammed SN, Hobson E, Smith A, Blyth M, Bennett C, Vasudevan PC, Garc&#x000ed;a-Mi&#x000f1;a&#x000fa;r S, Henderson A, Goodship J, Wright MJ, Fisher R, Gibbons R, Price SM, de Silva DC, Temple IK, Collins AL, Lachlan K, Elmslie F, McEntagart M, Castle B, Clayton-Smith J, Black GC, Donnai D. How genetically heterogeneous is Kabuki syndrome? MLL2 testing in 116 patients, review, and analyses of mutation and phenotypic spectrum. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:381–8.</span> [<a href="/pmc/articles/PMC3306863/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3306863</span></a>] [<a href="/pubmed/22126750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22126750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.benjamin.2017.125">Benjamin JS, Pilarowski GO, Carosso GA, Zhang L, Huso DL, Goff LA, Vernon HJ, Hansen KD, Bjornsson HT. A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2017;<span class="ref-vol">114</span>:125–130.</span> [<a href="/pmc/articles/PMC5224378/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5224378</span></a>] [<a href="/pubmed/27999180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27999180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.bernier.2017.e26">Bernier FE, Schreiber A, Coulombe J, Hatami A, Marcoux D. Pilomatricoma associated with Kabuki syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2017;<span class="ref-vol">34</span>:e26–7.</span> [<a href="/pubmed/27778401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27778401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.bjornsson.2014.256ra135">Bjornsson HT, Benjamin JS, Zhang L, Weissman J, Gerber EE, Chen YC, Vaurio RG, Potter MC, Hansen KD, Dietz HC. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. <span><span class="ref-journal">Sci Transl Med. </span>2014;<span class="ref-vol">6</span>:256ra135.</span> [<a href="/pmc/articles/PMC4406328/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4406328</span></a>] [<a href="/pubmed/25273096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25273096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.b_gershausen.2013.201">B&#x000f6;gershausen N, Wollnik B. Unmasking Kabuki syndrome. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:201–11.</span> [<a href="/pubmed/23131014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23131014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.b_gershausen.2016.847">B&#x000f6;gershausen N, Gatinois V, Riehmer V, Kayserili H, Becker J, Thoenes M, Simsek-Kiper P&#x000d6;, Barat-Houari M, Elcioglu NH, Wieczorek D, Tinschert S, Sarrabay G, Strom TM, Fabre A, Baynam G, Sanchez E, N&#x000fc;rnberg G, Altunoglu U, Capri Y, Isidor B, Lacombe D, Corsini C, Cormier-Daire V, Sanlaville D, Giuliano F, Le Quan Sang KH, Kayirangwa H, N&#x000fc;rnberg P, Meitinger T, Boduroglu K, Zoll B, Lyonnet S, Tzschach A, Verloes A, Di Donato N, Touitou I, Netzer C, Li Y, Genevi&#x000e8;ve D, Yigit G, Wollnik B. Mutation update for Kabuki syndrome genes KMT2D and KDM6A and further delineation of X-linked Kabuki syndrome subtype 2. <span><span class="ref-journal">Hum Mutat. </span>2016;<span class="ref-vol">37</span>:847–64.</span> [<a href="/pubmed/27302555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27302555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.brackmann.2013.e314">Brackmann F, Krumbholz M, Langer T, Rascher W, Holter W, Metzler M. Novel MLL2 mutation in Kabuki syndrome with hypogammaglobulinemia and severe chronic thrombopenia. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2013;<span class="ref-vol">35</span>:e314–6.</span> [<a href="/pubmed/23042018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23042018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.butcher.2017.773">Butcher DT, Cytrynbaum C, Turinsky AL, Siu MT, Inbar-Feigenberg M, Mendoza-Londono R, Chitayat D, Walker S, Machado J, Caluseriu O, Dupuis L, Grafodatskaya D, Reardon W, Gilbert-Dussardier B, Verloes A, Bilan F, Milunsky JM, Basran R, Papsin B, Stockley TL, Scherer SW, Choufani S, Brudno M, Weksberg R. CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">100</span>:773–88.</span> [<a href="/pmc/articles/PMC5420353/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5420353</span></a>] [<a href="/pubmed/28475860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28475860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.caciolo.2018.322">Caciolo C, Alfieri P, Piccini G, Digilio MC, Lepri FR, Tartaglia M, Menghini D, Vicari S. Neurobehavioral features in individuals with Kabuki syndrome. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2018;<span class="ref-vol">6</span>:322–31.</span> [<a href="/pmc/articles/PMC6014453/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6014453</span></a>] [<a href="/pubmed/29536651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29536651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.chen.2014.143">Chen YH, Sun MH, Hsia SH, Lai CC, Wu WC. Rare ocular features in a case of Kabuki syndrome (Niikawa-Kuroki syndrome). <span><span class="ref-journal">BMC Ophthalmol. </span>2014;<span class="ref-vol">14</span>:143.</span> [<a href="/pmc/articles/PMC4251844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4251844</span></a>] [<a href="/pubmed/25421742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25421742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.cheon.2015.317">Cheon CK, Ko JM. Kabuki syndrome: clinical and molecular characteristics. <span><span class="ref-journal">Korean J Pediatr. </span>2015;<span class="ref-vol">58</span>:317–24.</span> [<a href="/pmc/articles/PMC4623449/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4623449</span></a>] [<a href="/pubmed/26512256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26512256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.cheon.2014.321">Cheon CK, Sohn YB, Ko JM, Lee YJ, Song JS, Moon JW, Yang BK, Ha IS, Bae EJ, Jin HS, Jeong SY. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome. <span><span class="ref-journal">J Hum Genet. </span>2014;<span class="ref-vol">59</span>:321–5.</span> [<a href="/pubmed/24739679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24739679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.ciprero.2005.273">Ciprero KL, Clayton-Smith J, Donnai D, Zimmerman RA, Zackai EH, Ming JE. Symptomatic Chiari I malformation in Kabuki syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:273–5.</span> [<a href="/pubmed/15523623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.cocciadiferro.2018.3651">Cocciadiferro D, Augello B, De Nittis P, Zhang J, Mandriani B, Malerba N, Squeo GM, Romano A, Piccinni B, Verri T, Micale L, Pasqualucci L, Merla G. Dissecting KMT2D missense mutations in Kabuki syndrome patients. <span><span class="ref-journal">Hum Mol Genet. </span>2018;<span class="ref-vol">27</span>:3651–68.</span> [<a href="/pmc/articles/PMC6488975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6488975</span></a>] [<a href="/pubmed/30107592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30107592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.courcet.2013.742">Courcet JB, Faivre L, Michot C, Burguet A, Perez-Martin S, Alix E, Amiel J, Baumann C, Cordier MP, Cormier-Daire V, Delrue MA, Gilbert-Dussardier B, Goldenberg A, Jacquemont ML, Jaquette A, Kayirangwa H, Lacombe D, Le Merrer M, Toutain A, Odent S, Moncla A, Pelet A, Philip N, Pinson L, Poisson S, Kim-Han-Ie QS, Roume J, Sanchez E, Willems M, Till M, Vincent-Delorme C, Mousson C, Vinault S, Binquet C, Huet F, Sarda P, Salomon R, Lyonnet S, Sanlaville D, Genevi&#x000e8;ve D. Clinical and molecular spectrum of renal malformations in Kabuki syndrome. <span><span class="ref-journal">J Pediatr. </span>2013;<span class="ref-vol">163</span>:742–6.</span> [<a href="/pubmed/23535010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23535010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.digilio.2017.2912">Digilio MC, Gnazzo M, Lepri F, Dentici ML, Pisaneschi E, Baban A, Passarelli C, Capolino R, Angioni A, Novelli A, Marino B, Dallapiccola B. Congenital heart defects in molecularly proven Kabuki syndrome patients. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:2912–22.</span> [<a href="/pubmed/28884922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28884922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.ford.2015.178">Ford DJ, Dingwall AK. The cancer COMPASS: navigating the functions of MLL complexes in cancer. <span><span class="ref-journal">Cancer Genet. </span>2015;<span class="ref-vol">208</span>:178–91.</span> [<a href="/pubmed/25794446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25794446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.giordano.2014.10">Giordano P, Lassandro G, Sangerardi M, Faienza MF, Valente F, Martire B. Autoimmune haematological disorders in two Italian children with Kabuki syndrome. <span><span class="ref-journal">Ital J Pediatr. </span>2014;<span class="ref-vol">40</span>:10.</span> [<a href="/pmc/articles/PMC3917534/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3917534</span></a>] [<a href="/pubmed/24460868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24460868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.hannibal.2011.1511">Hannibal MC, Buckingham KJ, Ng SB, Ming JE, Beck AE, McMillin MJ, Gildersleeve HI, Bigham AW, Tabor HK, Mefford HC, Cook J, Yoshiura K, Matsumoto T, Matsumoto N, Miyake N, Tonoki H, Naritomi K, Kaname T, Nagai T, Ohashi H, Kurosawa K, Hou JW, Ohta T, Liang D, Sudo A, Morris CA, Banka S, Black GC, Clayton-Smith J, Nickerson DA, Zackai EH, Shaikh TH, Donnai D, Niikawa N, Shendure J, Bamshad MJ. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1511–6.</span> [<a href="/pmc/articles/PMC3121928/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3121928</span></a>] [<a href="/pubmed/21671394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21671394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.hong.2007.18439">Hong S, Cho YW, Yu LR, Yu H, Veenstra TD, Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:18439–44.</span> [<a href="/pmc/articles/PMC2141795/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2141795</span></a>] [<a href="/pubmed/18003914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18003914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.huether.2014.3630">Huether R, Dong L, Chen X, Wu G, Parker M, Wei L, Ma J, Edmonson MN, Hedlund EK, Rusch MC, Shurtleff SA, Mulder HL, Boggs K, Vadordaria B, Cheng J, Yergeau D, Song G, Becksfort J, Lemmon G, Weber C, Cai Z, Dang J, Walsh M, Gedman AL, Faber Z, Easton J, Gruber T, Kriwacki RW, Partridge JF, Ding L, Wilson RK, Mardis ER, Mullighan CG, Gilbertson RJ, Baker SJ, Zambetti G, Ellison DW, Zhang J, Downing JR. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:3630.</span> [<a href="/pmc/articles/PMC4119022/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4119022</span></a>] [<a href="/pubmed/24710217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24710217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.karagianni.2016.1333">Karagianni P, Lambropoulos V, Stergidou D, Fryssira H, Chatziioannidis I, Spyridakis I. Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:1333–8.</span> [<a href="/pubmed/26898171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26898171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.kouzarides.2007.693">Kouzarides T. Chromatin modifications and their function. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">128</span>:693–705.</span> [<a href="/pubmed/17320507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17320507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lederer.2012.119">Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, Maystadt I, Dallapiccola B, Verellen-Dumoulin C. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:119–24.</span> [<a href="/pmc/articles/PMC3257878/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257878</span></a>] [<a href="/pubmed/22197486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22197486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lederer.2014.1289">Lederer D, Shears D, Benoit V, Verellen-Dumoulin C, Maystadt I. A three generation X-linked family with Kabuki syndrome phenotype and a frameshift mutation in KDM6A. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1289–92.</span> [<a href="/pubmed/24664873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24664873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lehman.2017.298">Lehman N, Mazery AC, Visier A, Baumann C, Lachesnais D, Capri Y, Toutain A, Odent S, Mikaty M, Goizet C, Taupiac E, Jacquemont ML, Sanchez E, Schaefer E, Gatinois V, Faivre L, Minot D, Kayirangwa H, Sang KLQ, Boddaert N, Bayard S, Lacombe D, Moutton S, Touitou I, Rio M, Amiel J, Lyonnet S, Sanlaville D, Picot MC, Genevi&#x000e8;ve D. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:298–305.</span> [<a href="/pubmed/28295206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28295206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lepri.2017.e82">Lepri FR, Cocciadiferro D, Augello B, Alfieri P, Pes V, Vancini A, Caciolo C, Squeo GM, Malerba N, Adipietro I, Novelli A, Sotgiu S, Gherardi R, Digilio MC, Dallapiccola B, Merla G. Clinical and neurobehavioral features of three novel Kabuki syndrome patient with mosaic KMT2D mutations and a review of the literature. <span><span class="ref-journal">Int J Mol Sci. </span>2017;<span class="ref-vol">19</span>:E82.</span> pii. [<a href="/pmc/articles/PMC5796032/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5796032</span></a>] [<a href="/pubmed/29283410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29283410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.li.2011.715">Li Y, B&#x000f6;gershausen N, Alanay Y, Simsek Kiper PO, Plume N, Keupp K, Pohl E, Pawlik B, Rachwalski M, Milz E, Thoenes M, Albrecht B, Prott EC, Lehmk&#x000fc;hler M, Demuth S, Utine GE, Boduroglu K, Frankenbusch K, Borck G, Gillessen-Kaesbach G, Yigit G, Wieczorek D, Wollnik B. A mutation screen in patients with Kabuki syndrome. <span><span class="ref-journal">Hum Genet. </span>2011;<span class="ref-vol">130</span>:715–24.</span> [<a href="/pubmed/21607748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21607748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lin.2015.255">Lin JL, Lee WI, Huang JL, Chen PK, Chan KC, Lo LJ, You YJ, Shih YF, Tseng TY, Wu MC. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">88</span>:255–60.</span> [<a href="/pubmed/25142838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25142838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lindgren.2013.537">Lindgren AM, Hoyos T, Talkowski ME, Hanscom C, Blumenthal I, Chiang C, Ernst C, Pereira S, Ordulu Z, Clericuzio C, Drautz JM, Rosenfeld JA, Shaffer LG, Velsher L, Pynn T, Vermeesch J, Harris DJ, Gusella JF, Liao EC, Morton CC. Haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palate. <span><span class="ref-journal">Hum Genet. </span>2013;<span class="ref-vol">132</span>:537–52.</span> [<a href="/pmc/articles/PMC3627823/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3627823</span></a>] [<a href="/pubmed/23354975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23354975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.lindsley.2016.179">Lindsley AW, Saal HM, Burrow TA, Hopkin RJ, Shchelochkov O, Khandelwal P, Xie C, Bleesing J, Filipovich L, Risma K, Assa'ad AH, Roehrs PA, Bernstein JA. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2016;<span class="ref-vol">137</span>:179–87.e10.</span> [<a href="/pmc/articles/PMC4715656/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4715656</span></a>] [<a href="/pubmed/26194542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26194542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.liu.2015.26">Liu S, Hong X, Shen C, Shi Q, Wang J, Xiong F, Qiu Z. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. <span><span class="ref-journal">BMC Med Genet. </span>2015;<span class="ref-vol">16</span>:26.</span> [<a href="/pmc/articles/PMC4630853/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4630853</span></a>] [<a href="/pubmed/25896430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25896430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.makrythanasis.2013.539">Makrythanasis P, van Bon BW, Steehouwer M, Rodr&#x000ed;guez-Santiago B, Simpson M, Dias P, Anderlid BM, Arts P, Bhat M, Augello B, Biamino E, Bongers EM, Del Campo M, Cordeiro I, Cueto-Gonz&#x000e1;lez AM, Cusc&#x000f3; I, Deshpande C, Frysira E, Izatt L, Flores R, Gal&#x000e1;n E, Gener B, Gilissen C, Granneman SM, Hoyer J, Yntema HG, Kets CM, Koolen DA, Marcelis CL, Medeira A, Micale L, Mohammed S, de Munnik SA, Nordgren A, Reardon SP, Revencu N, Roscioli T, Ruiterkamp-Versteeg M, Santos HG, Schoumans J, Schuurs-Hoeijmakers JH, Silengo MC, Toledo L, Vendrell T, van der Burgt I, van Lier B, Zweier C, Reymond A, Trembath RC, Perez-Jurado L, Dupont J, de Vries BB, Brunner HG, Veltman JA, Merla G, Antonarakis SE, Hoischen A. MLL2 mutation detected in 86 patients with Kabuki syndrome; a genotype-phenotype study. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:539–45.</span> [<a href="/pubmed/23320472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23320472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.mcveigh.2015.135">McVeigh TP, Banka S, Reardon W. Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia. <span><span class="ref-journal">Clin Dysmorphol. </span>2015;<span class="ref-vol">24</span>:135–9.</span> [<a href="/pubmed/26049589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26049589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.micale.2011.38">Micale L, Augello B, Fusco C, Selicorni A, Loviglio MN, Silengo MC, Reymond A, Gumiero B, Zucchetti F, D'Addetta EV, Belligni E, Calcagn&#x000ec; A, Digilio MC, Dallapiccola B, Faravelli F, Forzano F, Accadia M, Bonfante A, Clementi M, Daolio C, Douzgou S, Ferrari P, Fischetto R, Garavelli L, Lapi E, Mattina T, Melis D, Patricelli MG, Priolo M, Prontera P, Renieri A, Mencarelli MA, Scarano G, Monica MD, Toschi B, Turolla L, Vancini A, Zatterale A, Gabrielli O, Zelante L, Merla G. Mutation spectrum of MLL2 in a cohort of kabuki syndrome patients. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:38.</span> [<a href="/pmc/articles/PMC3141365/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3141365</span></a>] [<a href="/pubmed/21658225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21658225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.miyake.2013.108">Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K, Tsurusaki Y, Nakashima M, Saitsu H, Niikawa N, Matsumoto N. KDM6A point mutations cause Kabuki syndrome. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:108–10.</span> [<a href="/pubmed/23076834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23076834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.morgan.2015.1483">Morgan AT, Mei C, Da Costa A, Fifer J, Lederer D, Benoit V, McMillin MJ, Buckingham KJ, Bamshad MJ, Pope K, White SM. Speech and language in a genotyped cohort of individuals with Kabuki syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2015;2015;<span class="ref-vol">167</span>:1483–92.</span> [<a href="/pubmed/25755104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25755104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.niikawa.1988.565">Niikawa N, Kuroki Y, Kajii T, Matsuura N, Ishikiriyama S, Tonoki H, Yamada Y, Fujita M, Umemoto H, Yoshimitsu Fukushima Y, Nako Y, Matsui I, Urakami T, Aritaki S, Hara M, Suzuki Y, Chyo H, Sugio Y, Hasegawa T, Yamanaka T, Tsukino R, Yoshida A, Nomoto N, Kawahito S, Aihara R, Toyota S, Ieshima A, Funaki H, Ishitobi K, Ogura S, Furumae T, Yoshino M, Tsuji Y, Kondoh T, Matsumoto T, Abe K, Harada N, Miike T, Ohdo S, Naritomi K, Abushwereb AK, Braun OH, Schmid E. Kabuki make-up (Niikawa-Kuroki) syndrome: A study of 62 patients. <span><span class="ref-journal">Am J Med Genet. </span>1988;<span class="ref-vol">31</span>:565–89.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.pad_rov_.2016.230">Pad&#x0011b;rov&#x000e1; J, Holubov&#x000e1; A, Simandlov&#x000e1; M, Puchmajerov&#x000e1; A, Vl&#x0010d;kov&#x000e1; M, Mal&#x000ed;kov&#x000e1; M, Pourov&#x000e1; R, Vejvalkov&#x000e1; S, Havlovicov&#x000e1; M, &#x00160;enke&#x00159;&#x000ed;kov&#x000e1; M, Pt&#x000e1;kov&#x000e1; N, Dr&#x000e1;bov&#x000e1; J, Geryk J, Maver A, K&#x00159;epelov&#x000e1; A, Macek M Jr. Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">90</span>:230–7.</span> [<a href="/pubmed/26841933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26841933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.paik.2016.474">Paik JM, Lim SY. Kabuki syndrome with cleft palate. <span><span class="ref-journal">Arch Plast Surg. </span>2016;<span class="ref-vol">43</span>:474–6.</span> [<a href="/pmc/articles/PMC5040853/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5040853</span></a>] [<a href="/pubmed/27689058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27689058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.paulussen.2011.e2018">Paulussen AD, Stegmann AP, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y, Smeets EE, Wagemans A, Schrander JJ, van den Boogaard MJ, van der Smagt J, van Haeringen A, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Mancini GM, Wessels MW, Hennekam RC, Vreeburg M, Geraedts J, de Ravel T, Fryns JP, Smeets HJ, Devriendt K, Schrander-Stumpel CT. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:E2018–25.</span> [<a href="/pubmed/21280141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21280141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.porntaveetus.2018.381">Porntaveetus T, Abid MF, Theerapanon T, Srichomthong C, Ohazama A, Kawasaki K, Kawasaki M, Suphapeetiporn K, Sharpe PT, Shotelersuk V. Expanding the Oro-Dental and Mutational Spectra of Kabuki Syndrome and Expression of KMT2D and KDM6A in Human Tooth Germs. <span><span class="ref-journal">Int J Biol Sci. </span>2018;<span class="ref-vol">14</span>:381–9.</span> [<a href="/pmc/articles/PMC5930470/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5930470</span></a>] [<a href="/pubmed/29725259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29725259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.rao.2015.334">Rao RC, Dou Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. <span><span class="ref-journal">Nat Rev Cancer. </span>2015;<span class="ref-vol">15</span>:334–46.</span> [<a href="/pmc/articles/PMC4493861/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4493861</span></a>] [<a href="/pubmed/25998713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25998713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.riess.2012.94">Riess A, Dufke A, Riess O, Beck-Woedl S, Fode B, Skladny H, Klaes R, Tzschach A. Mirror-image asymmetry in monozygotic twins with kabuki syndrome. <span><span class="ref-journal">Mol Syndromol. </span>2012;<span class="ref-vol">3</span>:94–7.</span> [<a href="/pmc/articles/PMC3542933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3542933</span></a>] [<a href="/pubmed/23326255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23326255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.roma.2015.80">Roma D, Palma P, Capolino R, Fig&#x000e0;-Talamanca L, Diomedi-Camassei F, Lepri FR, Digilio MC, Marras CE, Messina R, Carai A, Randi F, Mastronuzzi A. Spinal ependymoma in a patient with Kabuki syndrome: a case report. <span><span class="ref-journal">BMC Med Genet. </span>2015;<span class="ref-vol">16</span>:80.</span> [<a href="/pmc/articles/PMC4560867/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4560867</span></a>] [<a href="/pubmed/26341229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26341229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.sakata.2017.210">Sakata S, Okada S, Aoyama K, Hara K, Tani C, Kagawa R, Utsunomiya-Nakamura A, Miyagawa S, Ogata T, Mizuno H, Kobayashi M. Individual clinically diagnosed with CHARGE syndrome but with a mutation in KMT2D, a gene associated with Kabuki syndrome: a case report. <span><span class="ref-journal">Front Genet. </span>2017;<span class="ref-vol">8</span>:210.</span> [<a href="/pmc/articles/PMC5732153/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5732153</span></a>] [<a href="/pubmed/29321794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29321794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.schott.2016a.3172">Schott DA, Blok MJ, Gerver WJ, Devriendt K, Zimmermann LJ, Stumpel CT. Growth pattern in Kabuki syndrome with a KMT2D mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2016a;<span class="ref-vol">170</span>:3172–9.</span> [<a href="/pubmed/27530205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27530205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.schott.2016b.319">Schott DA, Gerver WJM, Stumpel CTRM. Growth hormone stimulation tests in children with Kabuki syndromeome. <span><span class="ref-journal">Horm Res Paediatr. </span>2016b;<span class="ref-vol">86</span>:319–24.</span> [<a href="/pubmed/27649541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27649541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.schulz.2019.614">Schulz WA, Lang A, Koch J, Greife A. The histone demethylase UTX/KDM6A in cancer: progress and puzzles. <span><span class="ref-journal">Int J Cancer. </span>2019;<span class="ref-vol">145</span>:614–20.</span> [<a href="/pubmed/30628063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30628063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.sert_elik.2016.280">Sert&#x000e7;elik M, U&#x0011f;ur &#x000c7;, &#x0015e;ahin Ak&#x000f6;zel A, G&#x000fc;rkan CK. A child with Kabuki syndrome and autism spectrum disorder. <span><span class="ref-journal">Noro Psikiyatr Ars. </span>2016;<span class="ref-vol">53</span>:280–2.</span> [<a href="/pmc/articles/PMC5378211/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5378211</span></a>] [<a href="/pubmed/28373809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28373809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.siminas.2015.54">Siminas S, Baillie CT, Turnock R. Kabuki syndrome and anorectal malformations: implications for diagnosis and treatment. <span><span class="ref-journal">European J Pediatr Surg Rep. </span>2015;<span class="ref-vol">3</span>:54–8.</span> [<a href="/pmc/articles/PMC4487125/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4487125</span></a>] [<a href="/pubmed/26171318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26171318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.teranishi.2018.391">Teranishi H, Koga Y, Nakashima K, Morihana E, Ishii K, Sakai Y, Taguchi T, Oda Y, Miyake N, Matsumoto N, Ohga S. Cancer management in Kabuki syndrome: the first case of Wilms tumor and a literature review. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2018;<span class="ref-vol">40</span>:391–4.</span> [<a href="/pubmed/29489735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29489735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.van_laarhoven.2015.4443">Van Laarhoven PM, Neitzel LR, Quintana AM, Geiger EA, Zackai EH, Clouthier DE, Artinger KB, Ming JE, Shaikh TH. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:4443–53.</span> [<a href="/pmc/articles/PMC4492403/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4492403</span></a>] [<a href="/pubmed/25972376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25972376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.vesseur.2016.129">Vesseur A, Cillessen E, Mylanus E. Cochlear implantation in a patient with Kabuki syndrome. <span><span class="ref-journal">J Int Adv Otol. </span>2016;<span class="ref-vol">12</span>:129–31.</span> [<a href="/pubmed/27341000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27341000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.white.2004.118">White SM, Thompson EM, Kidd A, Savarirayan R, Turner A, Amor D, Delatycki MB, Fahey M, Baxendale A, White S, Haan E, Gibson K, Halliday JL, Bankier A. Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">127A</span>:118–27.</span> [<a href="/pubmed/15108197" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15108197</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.yap.2019.262">Yap KL, Johnson AEK, Fischer D, Kandikatla P, Deml J, Nelakuditi V, Halbach S, Jeha GS, Burrage LC, Bodamer O, Benavides VC, Lewis AM, Ellard S, Shah P, Cody D, Diaz A, Devarajan A, Truong L, Greeley SAW, De Le&#x000f3;-Crutchlow DD, Edmondson AC, Das S, Thornton P, Waggoner D, Del Gaudio D. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals. <span><span class="ref-journal">Genet Med. </span>2019;<span class="ref-vol">21</span>:262–5.</span> [<a href="/pubmed/30097611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30097611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kabuki.REF.zarate.2012.180">Zarate YA, Zhan H, Jones JR. Infrequent manifestations of Kabuki syndrome in a patient with novel MLL2 mutation. <span><span class="ref-journal">Mol Syndromol. </span>2012;<span class="ref-vol">3</span>:180–4.</span> [<a href="/pmc/articles/PMC3507269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3507269</span></a>] [<a href="/pubmed/23239960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23239960</span></a>]</div></li></ul></div></div><div id="kabuki.Chapter_Notes"><h2 id="_kabuki_Chapter_Notes_">Chapter Notes</h2><div id="kabuki.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 October 2019 (aa) Revision: <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance added to Summary</div></li><li class="half_rhythm"><div>28 January 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 May 2013 (aa) Revision: mutations in <i>KDM6A</i> associated with Kabuki syndrome; large <i>KMT2D</i> (formerly <i>MLL2</i>) deletions/duplications reported as causative of Kabuki syndrome; addition of proposed phenotypic scoring system</div></li><li class="half_rhythm"><div>1 September 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>8 July 2011 (ma) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK62111</span><span class="label">PMID: <a href="/pubmed/21882399" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21882399</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kmt2b-dystonia/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kos/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK62111&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK62111/?report=reader">PubReader</a></li><li><a href="/books/NBK62111/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK62111" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK62111" style="display:none" title="Cite this Page"><div class="bk_tt">Adam MP, Hudgins L, Hannibal M. Kabuki Syndrome. 2011 Sep 1 [Updated 2019 Oct 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK62111/pdf/Bookshelf_NBK62111.pdf">PDF version of this page</a> (553K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kabuki.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kabuki.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kabuki.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kabuki.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kabuki.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kabuki.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kabuki.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kabuki.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kabuki.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kabuki.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kabuki.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8085[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KMT2D</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7403[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KDM6A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2557486" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2557486" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2557486" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2557486" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30514738" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Kabuki syndrome: international consensus diagnostic criteria.</a><span class="source">[J Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Kabuki syndrome: international consensus diagnostic criteria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adam MP, Banka S, Bjornsson HT, Bodamer O, Chudley AE, Harris J, Kawame H, Lanpher BC, Lindsley AW, Merla G, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Genet. 2019 Feb; 56(2):89-95. Epub 2018 Dec 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301719" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MED12</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MED12</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lyons MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301699" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rubinstein-Taybi Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rubinstein-Taybi Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stevens CA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21882399" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21882399" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042a99dde0891169be5e93">Kabuki Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Kabuki Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:35:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B3A68E041FDC10000000004CA01E7&amp;ncbi_session=CE8B3A68E042A991_1226SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK62111%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK62111&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK62111/&amp;ncbi_pagename=Kabuki Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B3A68E042A991_1226SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>